Most adverse events are gastrointestinal, mild to moderate, and occur during dose escalation, with relatively few participants discontinuing treatment
Robert Gabbay, MD, PhD, Chief Scientific and Medical Officer Possible Side Effects The safety profile of Retatrutide is still being characterized through clinical trials
At Everest, we consider Retatrutide a promising next-generation therapy one that may offer deeper transformation for selected patients under careful medical supervision
It works by binding to GHRH receptors in the pituitary gland, stimulating the pulsatile release of endogenous growth hormone (GH)
Simple Daily GLP-1 Nutrition Routine What might a simple supplement routine look like
Michigan, Rhode Island, and Wisconsin are planning or considering restrictions, according to KFFs most recent survey